Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing

Nucleic Acids Research

Volumn 37, Issue 14, 2009, Pages 4603-4612

  Varley, Katherine E ^a   Mutch, David G ^a   Edmonston, Tina B ^b   Goodfellow, Paul J ^a   Mitra, Robi D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; PROTEIN MLH1;

ALLELE; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA BARCODING; ENDOMETRIUM CANCER; EPIGENETICS; GENE SEQUENCE; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; SANGER SEQUENCING; SEQUENCE ANALYSIS; SINGLE MOLECULE BISULFITE SEQUENCING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALLELES; DNA METHYLATION; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; EPIGENESIS, GENETIC; FEMALE; GENETIC VARIATION; HUMANS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SULFITES;

EID: 69049103181     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp457     Document Type: Article

References (50)

1. Aubele,M., Mattis,A., Zitzelsberger,H., Walch,A., Kremer,M., Hutzler,P., Hofler,H. and Werner,M. (1999) Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet. Cytogenet., 110, 94-102.
2. Baisse,B., Bouzourene,H., Saraga,E.P., Bosman,F.T. and Benhattar,J. (2001) Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int. J. Cancer, 93, 346-352.
3. Gonzalez-Garcia,I., Sole,R.V. and Costa,J. (2002) Metapopulation dynamics and spatial heterogeneity in cancer. Proc. Natl Acad. Sci. USA, 99, 13085-13089.
4. Shibata,D. (2006) When does MMR loss occur during HNPCC progression? Cancer Biomark., 2, 29-35.
5. Shibata,D. (2008) Stem cells as common ancestors in a colorectal cancer ancestral tree. Curr. Opin. Gastroenterol., 24, 59-63.
6. Branford,S., Rudzki,Z., Walsh,S., Grigg,A., Arthur,C., Taylor,K., Herrmann,R., Lynch,K.P. and Hughes,T.P. (2002) High frequency of point mutations clustered within the adenosine triphosphatebinding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood, 99, 3472-3475.
7. Gorre,M.E., Mohammed,M., Ellwood,K., Hsu,N., Paquette,R., Rao,P.N. and Sawyers,C.L. (2001) Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science, 293, 876-880.
8. Pao,W., Miller,V.A., Politi,K.A., Riely,G.J., Somwar,R., Zakowski,M.F., Kris,M.G. and Varmus,H. (2005) Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med., 2, e73.
9. Shah,N.P., Nicoll,J.M., Nagar,B., Gorre,M.E., Paquette,R.L., Kuriyan,J. and Sawyers,C.L. (2002) Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell, 2, 117-125.
10. Maley,C.C., Galipeau,P.C., Finley,J.C., Wongsurawat,V.J., Li,X., Sanchez,C.A., Paulson,T.G., Blount,P.L., Risques,R.A., Rabinovitch,P.S. et al. (2006) Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet., 38, 468-473.
11. Lyko,F. and Brown,R. (2005) DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J. Natl Cancer Inst., 97, 1498-1506.
12. Aggerholm,A., Guldberg,P., Hokland,M. and Hokland,P. (1999) Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res., 59, 436-441.
13. Bhawal,U.K., Tsukinoki,K., Sasahira,T., Sato,F., Mori,Y., Muto,N., Sugiyama,M. and Kuniyasu,H. (2007) Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer. Oncology Rep., 18 817-824.
14. Korshunova,Y., Maloney,R.K., Lakey,N., Citek,R.W., Bacher,B., Budiman,A., Ordway,J.M., McCombie,W.R., Leon,J., Jeddeloh,J.A. et al. (2008) Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancerassociated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res., 18 19-29.
15. Rastetter,M., Schagdarsurengin,U., Lahtz,C., Fiedler,E., Marsch,W., Dammann,R. and Helmbold,P. (2007) Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma. Histol. Histopathol., 22, 1005-1015.
16. Taylor,K.H., Kramer,R.S., Davis,J.W., Guo,J., Duff,D.J., Xu,D., Caldwell,C.W. and Shi,H. (2007) Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res., 67, 8511-8518.
17. Bronner,C.E., Baker,S.M., Morrison,P.T., Warren,G., Smith,L.G., Lescoe,M.K., Kane,M., Earabino,C., Lipford,J., Lindblom,A. et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature, 368, 258-261.
18. Papadopoulos,N., Nicolaides,N.C., Wei,Y.F., Ruben,S.M., Carter,K.C., Rosen,C.A., Haseltine,W.A., Fleischmann,R.D., Fraser,C.M., Adams,M.D. et al. (1994) Mutation of a mutL homolog in hereditary colon cancer. Science, 263, 1625-1629.
19. Lynch,H.T. and Lynch,J.F. (1994) 25 years of HNPCC. Anticancer Res. 14, 1617-1624.
20. Simpkins,S.B., Bocker,T., Swisher,E.M., Mutch,D.G., Gersell,D.J., Kovatich,A.J., Palazzo,J.P., Fishel,R. and Goodfellow,P.J. (1999) MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum. Mol. Genet., 8, 661-666.
21. Esteller,M., Catasus,L., Matias-Guiu,X., Mutter,G.L., Prat,J., Baylin,S.B. and Herman,J.G. (1999) hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am. J. Pathol., 155, 1767-1772.
22. Veigl,M.L., Kasturi,L., Olechnowicz,J., Ma,A.H., Lutterbaugh,J.D., Periyasamy,S., Li,G.M., Drummond,J., Modrich,P.L., Sedwick,W.D. et al. (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl Acad. Sci. USA, 95, 8698-8702.
23. Lahiri,D.K. and Nurnberger,J.I. Jr. (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res., 19, 5444.
24. Miller,S.A., Dykes,D.D. and Polesky,H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
25. Larkin,M.A., Blackshields,G., Brown,N.P., Chenna,R., McGettigan,P.A., McWilliam,H., Valentin,F., Wallace,I.M., Wilm,A., Lopez,R. et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics, 23, 2947-2948.
26. Boland,C.R., Thibodeau,S.N., Hamilton,S.R., Sidransky,D., Eshleman,J.R., Burt,R.W., Meltzer,S.J., Rodriguez-Bigas,M.A., Fodde,R., Ranzani,G.N. et al. (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58, 5248-5257.
27. Kowalski,L.D., Mutch,D.G., Herzog,T.J., Rader,J.S. and Goodfellow,P.J. (1997) Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER + endometrial cancers. Genes Chromosomes Cancer, 18, 219-227.
28. Xiong,Z. and Laird,P.W. (1997) COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res., 25, 2532-2534.
29. Whitcomb,B.P., Mutch,D.G., Herzog,T.J., Rader,J.S., Gibb,R.K. and Goodfellow,P.J. (2003) Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin. Cancer Res., 9, 2277-2287.
30. Case,A.S., Zighelboim,I., Mutch,D.G., Babb,S.A., Schmidt,A.P., Whelan,A.J., Thibodeau,S.N. and Goodfellow,P.J. (2008) Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair. Gynecol. Oncol., 108, 438-444.
31. Frommer,M., McDonald,L.E., Millar,D.S., Collis,C.M., Watt,F., Grigg,G.W., Molloy,P.L. and Paul,C.L. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA, 89, 1827-1831.
32. Clark,S.J., Harrison,J., Paul,C.L. and Frommer,M. (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22, 2990-2997.
33. Deng,G., Chen,A., Hong,J., Chae,H.S. and Kim,Y.S. (1999) Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res., 59, 2029-2033.
34. Chhibber,A. and Schroeder,B.G. (2008) Single-molecule polymerase chain reaction reduces bias: Application to DNA methylation analysis by bisulfite sequencing. Anal. Biochem., 377, 46-54.
35. Weisenberger,D.J., Trinh,B.N., Campan,M., Sharma,S., Long,T.I., Ananthnarayan,S., Liang,G., Esteva,F.J., Hortobagyi,G.N., McCormick,F. et al. (2008) DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res., 36, 4689-4698.
36. Whelan,A.J., Babb,S., Mutch,D.G., Rader,J., Herzog,T.J., Todd,C., Ivanovich,J.L. and Goodfellow,P.J. (2002) MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers. Int. J. Cancer, 99, 697-704.
37. Nowell,P.C. (1976) The clonal evolution of tumor cell populations. Science, 194, 23-28.
38. Issa,J.P. (2000) The epigenetics of colorectal cancer. Ann. NY Acad. Sci., 910, 140-153; discussion 153-145.
39. Pfeifer,G.P., Steigerwald,S.D., Hansen,R.S., Gartler,S.M. and Riggs,A.D. (1990) Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: Methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. Proc. Natl Acad. Sci. USA, 87, 8252-8256.
40. Bird,A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev., 16, 6-21.
41. Cameron,E.E., Baylin,S.B. and Herman,J.G. (1999) p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood, 94, 2445-2451.
42. Helmle,K.E., Otto,C.J., Constantinescu,G., Honore,L.H. and Andrew,S.E. (2005) Variable MLH1 promoter methylation patterns in endometrial carcinomas of endometrioid subtype lacking DNA mismatch repair. Int. J. Gynecol. Cancer, 15, 1089-1096.
43. Kanaya,T., Kyo,S., Maida,Y., Yatabe,N., Tanaka,M., Nakamura,M. and Inoue,M. (2003) Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers. Oncogene, 22 2352-2360.
44. Strazzullo,M., Cossu,A., Baldinu,P., Colombino,M., Satta,M.P., Tanda,F., De Bonis,M.L., Cerase,A., D'Urso,M., D'Esposito,M. et al. (2003) High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas. Cancer, 98, 1540-1546.
45. Bettstetter,M., Dechant,S., Ruemmele,P., Grabowski,M., Keller,G., Holinski-Feder,E., Hartmann,A., Hofstaedter,F. and Dietmaier,W. (2007) Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Clin. Cancer Res., 13, 3221-3228.
46. Beerenwinkel,N., Antal,T., Dingli,D., Traulsen,A., Kinzler,K.W., Velculescu,V.E., Vogelstein,B. and Nowak,M.A. (2007) Genetic progression and the waiting time to cancer. PLoS Comput. Biol., 3, e225.
47. Iwasa,Y., Michor,F., Komarova,N.L. and Nowak,M.A. (2005) Population genetics of tumor suppressor genes. J. Theoret. Biol., 233, 15-23.
48. Kim,J.Y., Tavare,S. and Shibata,D. (2005) Counting human somatic cell replications: Methylation mirrors endometrial stem cell divisions. Proc. Natl Acad. Sci. USA, 102, 17739-17744.
49. Nicolas,P., Kim,K.M., Shibata,D. and Tavare,S. (2007) The stem cell population of the human colon crypt: Analysis via methylation patterns. PLoS Comput. Biol., 3, e28.
50. Yatabe,Y., Tavare,S. and Shibata,D. (2001) Investigating stem cells in human colon by using methylation patterns. Proc. Natl Acad. Sci. USA 98, 10839-10844.